Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources

Overview of attention for article published in Patient preference and adherence, January 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study

Article in Multiple Sclerosis and Related Disorders (November 2023)

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study

Article in Journal of Clinical Medicine (July 2023)

How to choose initial treatment in multiple sclerosis patients: a case-based approach

Article in Arquivos de Neuro-Psiquiatria (May 2022)